HSPA5 and acute myeloid leukemia: GRP78 was proven to be highly expressed on the cell surface of AML patients’ peripheral blood cells, and it is also over-expressed in chronic lymphocytic leukemia patients’ cells than in normal B cells, but not in T cells (Huergo-Zapico et al., 2012; Staquicini et al., 2018).